SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-019724
Filing Date
2024-03-05
Accepted
2024-03-05 06:11:11
Documents
16
Period of Report
2024-02-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0201207-8k_incannex.htm   iXBRL 8-K 29772
2 EMPLOYMENT AGREEMENT, DATED FEBRUARY 27, 2024, BETWEEN INCANNEX HEALTHCARE INC. ea0201207ex10-1_incannex.htm EX-10.1 170143
3 GRAPHIC ex10-1_001.jpg GRAPHIC 3373
  Complete submission text file 0001213900-24-019724.txt   397856

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ixhl-20240229.xsd EX-101.SCH 3024
5 XBRL LABEL FILE ixhl-20240229_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ixhl-20240229_pre.xml EX-101.PRE 22365
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0201207-8k_incannex_htm.xml XML 3715
Mailing Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008
Business Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 24718191
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)